Frans Brandt

Frans Brandt

Auto-generated profile, based on publicly available information

Frans Brandt

Internal Medicine Research Unit, University Hospital of Southern Denmark, 6200 Aabenraa, Denmark

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
JKJan D. Kampmann
Jan D. Kampmann
JHJames Heaf
James Heaf
CMChristian Backer Mogensen
Christian Backer Mogensen
APAndreas Kristian Pedersen
Andreas Kristian Pedersen
JGJeff Granhøj
Jeff Granhøj
FBFrans Brandt
Frans Brandt
Identifying acute myocardial infarction in patients with renal disease is notoriously difficult, due to atypical presentation and chronically elevated troponin. The aim of this study was to identify a specific troponin T/troponin I cut-off value for diagnosis of acute myocardial infarction in patients with renal impairment via meta-analysis. Two investigators screened 2590 publications from MEDLINE, Embase, PubMed, Web of Science, and the Cochrane library. Only studies that investigated alternative cut-offs according to renal impairment were included. Fifteen articles fulfilled the inclusion criteria. Six studies were combined for meta-analysis. The manufacturer’s upper reference level for troponin T is 14 ng/L. Based on the meta-analyses, cut-off values for troponin in patients with renal impairment with myocardial infarction was 42 ng/L for troponin I and 48 ng/L for troponin T. For patients on dialysis the troponin T cut-off is even higher at 239 ng/L. A troponin I cut-off value for dialysis patients could not be established due to lack of data. The 15 studies analyzed showed considerable diversity in study design, study population, and the definition of myocardial infarction. Further studies are needed to define a reliable troponin cut-off value for patients with kidney disease, especially in dialysis patients, and to allow necessary subanalysis.

CJCamilla Jøhnk
Camilla Jøhnk
HLHelene Holm Laigaard
Helene Holm Laigaard
APAndreas Kristian Pedersen
Andreas Kristian Pedersen
EBEithne Hayes Bauer
Eithne Hayes Bauer
FBFrans Brandt
Frans Brandt
DWdonna lykke wolff
donna lykke wolff
Increasing numbers of patients are being referred to specialised palliative care (SPC) which, in order to be beneficial, is recommended to last more than three months. This cohort study aimed to describe time to end-of-life after initiating SPC treatment and to explore potential regional variations. We used national register data from all Danish hospital SPC teams. We included patients who started SPC treatment from 2015–2018 to explore if time to end-of-life was longer than three months. Descriptive statistics were used to summarise the data and a generalised linear model was used to assess variations among the five Danish regions. A total of 27,724 patients were included, of whom 36.7% (95% CI 36.2–37.1%) had over three months to end-of-life. In the Capital Region of Denmark, 40.1% (95% CI 39.0–41.3%) had over three months to end-of-life versus 32.5% (95% CI 30.9–34.0%) in North Denmark Region. We conclude that most patients live for a shorter period of time than the recommended three months after initiating SPC treatment. This is neither optimal for patient care, nor the healthcare system. A geographical variation between regions was shown indicating different practices, patient groups or resources. These results warrant further investigation to promote optimal SPC treatment.

12 May 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
JAJohan Frederik Lillebø Alsing
Johan Frederik Lillebø Alsing
EBEithne Hayes Bauer
Eithne Hayes Bauer
FBFrans Brandt
Frans Brandt
JKJan D. Kampmann
Jan D. Kampmann
Existing studies display a huge disparity in terms of the number of patients who regret having engaged in dialysis. Modifiable care processes such as providing sufficient information and education prior to decision-making have been shown to have a greater impact on patient satisfaction. Despite the importance of regret as a measure of the quality of the dialysis decision-making process, few studies have examined regret following dialysis initiation. Aim: To explore the expectations and experiences of patients who have recently started centre-based dialysis treatment. Methods: A qualitative explorative study of centre-based dialysis patients was performed. Data were collected using focus group discussions of 2–4 patients. The study was guided by interpretive description and thematic analysis was used to analyse data. Results: Three focus group discussions were performed. Participants (n = 8) consisted of six men and two women aged 54 to 80 years of age with a median age of 72. Three themes emerged from the data: 1. transition from being a non-dialysis patient to becoming a dialysis patient, 2. physical condition following initiation of dialysis treatment, and 3. limitations and social disruptions. Conclusion: The initiation of dialysis disrupted daily life in terms of fluctuating fatigue, strict schedules, and time lost. There was a loss of independence, and participants did not view dialysis as an active choice. Nurses may have a significant impact on the perception of dialysis. This study highlights the need for further research to develop interventions to support newly initiated centre-based dialysis patients to transition from non-dialysis to dialysis patients.

Verified
Journal Article
Open access
PDF file
JKJan D. Kampmann
Jan D. Kampmann
JHJames Goya Heaf
James Goya Heaf
CMChristian Backer Mogensen
Christian Backer Mogensen
SPSofie Ronja Petersen
Sofie Ronja Petersen
DWdonna lykke wolff
donna lykke wolff
FBFrans Brandt
Frans Brandt
Chronic kidney disease (CKD) is a known risk factor for cardiovascular disease, including acute myocardial infarction. However, whether this risk is only associated with severe kidney disease or is also related to mildly impaired kidney function is still under debate. The incidence rate and risk factors of incident acute myocardial infarction (AMI) in patients with CKD are sparse. Potential differences in risk factor profiles between CKD patients with incident AMI and CKD patients with a prior AMI have not been sufficiently investigated. Furthermore, important factors such as albuminuria and socio-economic factors are often not included. The primary aim of this study was to establish the incidence rate of AMI after CKD debut. Secondly, to evaluate the importance of different CKD stages and the risk of having an AMI. Finally, to identify individuals at risk for AMI after CKD debut adjusted for prevalent AMI. Based on data from the kidney disease cohort of Southern Denmark (KidDiCo), including 66,486 CKD patients, we established incidence rates and characteristics of incident AMI among patients within a 5-year follow-up period after CKD debut. A Cox regression was performed to compute the cause-specific hazard ratios for the different risk factors. The incidence rate for CKD stage G3–5 patients suffering acute myocardial infarction is 2.5 cases/1000 people/year. In patients without a previous myocardial infarction, the risk of suffering a myocardial infarction after CKD debut was only significant in CKD stage G4 (HR = 1.402; (95% CI: 1.08–1.81); p-value = 0.010) and stage G5 (HR = 1.491; (95% CI: 1.01–2.19); p-value = 0.042). This was not the case in patients who had suffered an acute myocardial infarction prior to their CKD debut. In this group, a previous myocardial infarction was the most critical risk factor for an additional myocardial infarction after CKD debut (HR = 2.615; (95% CI: 2.241–3.05); p-value < 0.001). Irrespective of a previous myocardial infarction, age, male sex, hypertension, and a low educational level were significant risk factors associated with an acute myocardial infarction after CKD debut. The incidence rate of AMI in patients with CKD stage G3–5 was 2.5 cases/1000 people/year. Risk factors associated with incident AMI in CKD stage G3–5 patients were CKD stage, age, and hypertension. Female sex and higher educational levels were associated with a lower risk for AMI. Prior AMI was the most significant risk factor in patients with and without previous AMI before fulfilling CKD stage G3–5 criteria. Only age, sex, and a medium-long educational level were significant risk factors in this group.

11 February 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
JKJan D. Kampmann
Jan D. Kampmann
NHNina Pirschel Hansen
Nina Pirschel Hansen
ASAnders Nikolai Schultz
Anders Nikolai Schultz
ABAndreas Hjelm Brandt
Andreas Hjelm Brandt
FBFrans Brandt
Frans Brandt
Background: Lanthanum carbonate is a phosphate binder used in advanced kidney disease. Its radiopaque appearance has been described in many case studies and case series. Misinterpretation of this phenomenon leads to unnecessary diagnostic tests and procedures. The objectives of this study were to summarize the literature on lanthanum carbonate opacities and present a visual overview. Methods: A systematic search was conducted using MEDLINE, Embase, and Web of Science. We included all types of studies, including case reports/studies, describing radiological findings of lanthanum carbonate opacities in patients with chronic kidney disease. No filter for time was set. Results: A total of 36 articles were eligible for data extraction, and 33 articles were included in the narrative synthesis. Lanthanum carbonate opacities were most commonly reported in the intestines (26 studies, 73%), stomach (8 studies, 21%), and the aerodigestive tract (2 studies, 6%). The opacities in the intestine were most frequently described as multiple, scattered radiopaque densities, compared with the aerodigestive tract, where the opacities were described as a single, round foreign body. Suspicion of contrast medium or foreign bodies was the most common differential diagnosis. LC opacities in patients with CKD are commonly misinterpreted as foreign bodies or suspect contrast media. Conclusions: CKD patients treated with LC may have opacities throughout the digestive tract that can vary in appearance. Stopping LC treatment or changing to an alternative phosphate binder prior to planned image studies can avoid diagnostic confusion. If this is not an option, knowledge of the presentation of LC opacities is important.

6 June 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
MSMariam Safi
Mariam Safi
BTBettina ravnborg Thude
Bettina ravnborg Thude
ECEmma Weiss Christensen
Emma Weiss Christensen
DJDorte Ejg Jarbøl
Dorte Ejg Jarbøl
NANeringa Andziule
Neringa Andziule
FBFrans Brandt
Frans Brandt
Background: This scoping review aimed to identify and evaluate interventions to improve timely detection and diagnosis of lung, ovarian, stomach, and pancreatic cancers among adults. Understanding the effectiveness of these interventions is important for improving cancer care and patient outcomes. Method: A scoping review was conducted following the JBI framework and the PRISMA-ScR Checklist to identify empirical studies reporting interventions focused on lung, stomach, ovarian, and pancreatic cancers. A systematic literature search was performed in three databases (CINAHL, Embase, and Medline). Supplementary searches included citation tracking. English-language empirical studies examining interventions for early cancer detection in adults were included. Open Science Framework was used to register the scoping review protocol (accessed on 11 July 2024). Results: Of 13,142 retrieved citations, 12 articles met the inclusion criteria. Studies were conducted in the UK (n = 6), Australia (n = 2), Northern Ireland (n = 1), Denmark (n = 1), and the USA (n = 2). Interventions included awareness campaigns, educational programmes, and improved access to health services. Interactive formats and clear messaging increased awareness and help-seeking behaviour. Integrated approaches combining public awareness campaigns with general practitioner educational programmes were associated with promoting timely diagnosis and improving survival rates. Tailored interventions targeting populations such as rural residents and long-term smokers enhanced effectiveness. Conclusion: The review highlights the importance of integrated strategies to improve early cancer detection and diagnosis. Three intervention types were identified: awareness campaigns, educational programmes, and direct access to health services. Future interventions should consider longer campaign durations and tailored approaches for demographic groups, particularly populations in deprived areas, to improve effectiveness.